345 related articles for article (PubMed ID: 26739236)
41. BAP1/ASXL complex modulation regulates epithelial-mesenchymal transition during trophoblast differentiation and invasion.
Perez-Garcia V; Lea G; Lopez-Jimenez P; Okkenhaug H; Burton GJ; Moffett A; Turco MY; Hemberger M
Elife; 2021 Jun; 10():. PubMed ID: 34170818
[TBL] [Abstract][Full Text] [Related]
42. BAP1 promotes the repair of UV-induced DNA damage via PARP1-mediated recruitment to damage sites and control of activity and stability.
Lee SA; Lee D; Kang M; Kim S; Kwon SJ; Lee HS; Seo HR; Kaushal P; Lee NS; Kim H; Lee C; Kwon J
Cell Death Differ; 2022 Dec; 29(12):2381-2398. PubMed ID: 35637285
[TBL] [Abstract][Full Text] [Related]
43. BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5.
Qin J; Zhou Z; Chen W; Wang C; Zhang H; Ge G; Shao M; You D; Fan Z; Xia H; Liu R; Chen C
Nat Commun; 2015 Sep; 6():8471. PubMed ID: 26419610
[TBL] [Abstract][Full Text] [Related]
44. BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN.
Deng R; Guo Y; Li L; He J; Qiang Z; Zhang H; Chen R; Wang Y; Zhao X; Yu J
Mol Oncol; 2021 Jan; 15(1):279-298. PubMed ID: 33155366
[TBL] [Abstract][Full Text] [Related]
45. An emerging model for BAP1's role in regulating cell cycle progression.
Eletr ZM; Wilkinson KD
Cell Biochem Biophys; 2011 Jun; 60(1-2):3-11. PubMed ID: 21484256
[TBL] [Abstract][Full Text] [Related]
46. BAP1 deletion abrogates growth and metastasis of murine cutaneous melanoma.
Luo X; Xu Y; Li Y; Zhang G; Huang S; Liu X; Ren Z; Liu S; Yu L
Melanoma Res; 2021 Apr; 31(2):119-129. PubMed ID: 33347048
[TBL] [Abstract][Full Text] [Related]
47. Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O.
Mashtalir N; Daou S; Barbour H; Sen NN; Gagnon J; Hammond-Martel I; Dar HH; Therrien M; Affar el B
Mol Cell; 2014 May; 54(3):392-406. PubMed ID: 24703950
[TBL] [Abstract][Full Text] [Related]
48. The tumor suppressor BAP1 cooperates with BRAFV600E to promote tumor formation in cutaneous melanoma.
Webster JD; Pham TH; Wu X; Hughes NW; Li Z; Totpal K; Lee HJ; Calses PC; Chaurushiya MS; Stawiski EW; Modrusan Z; Chang MT; Tran C; Lee WP; Chalasani S; Hung J; Sharma N; Chan S; Hotzel K; Talevich E; Shain A; Xu M; Lill J; Dixit VM; Bastian BC; Dey A
Pigment Cell Melanoma Res; 2019 Mar; 32(2):269-279. PubMed ID: 30156010
[TBL] [Abstract][Full Text] [Related]
49. Regulation of cell cycle progression and gene expression by H2A deubiquitination.
Joo HY; Zhai L; Yang C; Nie S; Erdjument-Bromage H; Tempst P; Chang C; Wang H
Nature; 2007 Oct; 449(7165):1068-72. PubMed ID: 17914355
[TBL] [Abstract][Full Text] [Related]
50. A Novel BRCA1-Associated Protein-1 Isoform Affects Response of Mesothelioma Cells to Drugs Impairing BRCA1-Mediated DNA Repair.
Parrotta R; Okonska A; Ronner M; Weder W; Stahel R; Penengo L; Felley-Bosco E
J Thorac Oncol; 2017 Aug; 12(8):1309-1319. PubMed ID: 28389374
[TBL] [Abstract][Full Text] [Related]
51. BAP1 links metabolic regulation of ferroptosis to tumour suppression.
Zhang Y; Shi J; Liu X; Feng L; Gong Z; Koppula P; Sirohi K; Li X; Wei Y; Lee H; Zhuang L; Chen G; Xiao ZD; Hung MC; Chen J; Huang P; Li W; Gan B
Nat Cell Biol; 2018 Oct; 20(10):1181-1192. PubMed ID: 30202049
[TBL] [Abstract][Full Text] [Related]
52. The forkhead transcription factor FOXK2 acts as a chromatin targeting factor for the BAP1-containing histone deubiquitinase complex.
Ji Z; Mohammed H; Webber A; Ridsdale J; Han N; Carroll JS; Sharrocks AD
Nucleic Acids Res; 2014 Jun; 42(10):6232-42. PubMed ID: 24748658
[TBL] [Abstract][Full Text] [Related]
53. The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigenetics.
Abdel-Wahab O; Dey A
Leukemia; 2013 Jan; 27(1):10-5. PubMed ID: 23147254
[TBL] [Abstract][Full Text] [Related]
54. Germline mutations in BAP1 impair its function in DNA double-strand break repair.
Ismail IH; Davidson R; Gagné JP; Xu ZZ; Poirier GG; Hendzel MJ
Cancer Res; 2014 Aug; 74(16):4282-94. PubMed ID: 24894717
[TBL] [Abstract][Full Text] [Related]
55. DNA damage triggers nucleotide excision repair-dependent monoubiquitylation of histone H2A.
Bergink S; Salomons FA; Hoogstraten D; Groothuis TA; de Waard H; Wu J; Yuan L; Citterio E; Houtsmuller AB; Neefjes J; Hoeijmakers JH; Vermeulen W; Dantuma NP
Genes Dev; 2006 May; 20(10):1343-52. PubMed ID: 16702407
[TBL] [Abstract][Full Text] [Related]
56. In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones.
Masclef L; Maxime U; Ahmed O; Sen Nkwe N; Barbour H; Iannantuono NVG; Boubekeur A; Daou S; Affar EB
J Vis Exp; 2019 Jul; (149):. PubMed ID: 31403616
[TBL] [Abstract][Full Text] [Related]
57. BAP1 is phosphorylated at serine 592 in S-phase following DNA damage.
Eletr ZM; Yin L; Wilkinson KD
FEBS Lett; 2013 Dec; 587(24):3906-11. PubMed ID: 24211834
[TBL] [Abstract][Full Text] [Related]
58. BAP1 regulates epigenetic switch from pluripotency to differentiation in developmental lineages giving rise to BAP1-mutant cancers.
Kuznetsov JN; Aguero TH; Owens DA; Kurtenbach S; Field MG; Durante MA; Rodriguez DA; King ML; Harbour JW
Sci Adv; 2019 Sep; 5(9):eaax1738. PubMed ID: 31555735
[TBL] [Abstract][Full Text] [Related]
59. Proteomic analysis identifies novel binding partners of BAP1.
Baas R; J van der Wal F; Bleijerveld OB; van Attikum H; Sixma TK
PLoS One; 2021; 16(9):e0257688. PubMed ID: 34591877
[TBL] [Abstract][Full Text] [Related]
60. BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization.
Ventii KH; Devi NS; Friedrich KL; Chernova TA; Tighiouart M; Van Meir EG; Wilkinson KD
Cancer Res; 2008 Sep; 68(17):6953-62. PubMed ID: 18757409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
